Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 209

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study

Open access
Ko, Tai-Ming, Tsai, Chang-Youh, Chen, Shih-Yang, Chen, Kuo-Shu, Yu, Kuang-Hui, Chu, Chih-Sheng, Huang, Chung-Ming, Wang, Chrong-Reen, Weng, Chia-Tse, Yu, Chia-Li, Hsieh, Song-Chou, Tsai, Jer-Chia, Lai, Wen-Ter, Tsai, Wen-Chan, Yin, Guang-Dar, Ou, Tsan-Teng, Cheng, Kai-Hung, Yen, Jeng-Hsien, Liou, Teh-Ling, Lin, Tsung-Hsien, Chen, Der-Yuan, Hsiao, Pi-Jung, Weng, Meng-Yu, Chen, Yi-Ming, Chen, Chen-Hung, Liu, Ming-Fei, Yen, Hsueh-Wei, Lee, Jia-Jung, Kuo, Mei-Chuan, Wu, Chen-Ching, Hung, Shih-Yuan, Luo, Shue-Fen, Yang, Ya-Hui, Chuang, Hui-Ping, Chou, Yi-Chun, Liao, Hung-Ting, Wang, Chia-Wen, Huang, Chun-Lin, Chang, Chia-Shuo, Lee, Ming-Ta Michael, Chen, Pei, Wong, Chih-Shung, Chen, Chien-Hsiun, Wu, Jer-Yuarn, Chen, Yuan-Tsong, Shen, Chen-Yang·2015·BMJ

Abstract

OBJECTIVE: To evaluate the use of prospective screening for the HLA-B*58:01 allele to identify Taiwanese individuals at risk of severe cutaneous adverse reactions (SCARs) induced by allopurinol treatment. DESIGN: National prospective cohort study. SETTING: 15 medical centres in different regions of Taiwan, from July 2009 to August 2014. PARTICIPANTS: 2926 people who had an indication for allopurinol treatment but had not taken allopurinol previously. Participants were excluded if they had undergone a bone marrow transplant, were not of Han Chinese descent, and had a history of allopurinol induced hypersensitivity. DNA purified from 2910 participants' peripheral blood was used to assess the presence of HLA-B*58:01. MAIN OUTCOME MEASURES: Incidence of allopurinol induced SCARs with and without screening. RESULTS: Participants who tested positive for HLA-B*58:01 (19.6%, n=571) were advised to avoid allopurinol, and were referred to an alternate drug treatment or advised to continue with their prestudy treatment. Participants who tested negative (80.4%, n=2339) were given allopurinol. Participants were interviewed once a week for two months to monitor symptoms. The historical incidence of allopurinol induced SCARs, estimated by the National Health Insurance research database of Taiwan, was used for comparison. Mild, transient rash without blisters developed in 97 (3%) participants during follow-up. None of the participants was admitted to hospital owing to adverse drug reactions. SCARs did not develop in any of the participants receiving allopurinol who screened negative for HLA-B*58:01. By contrast, seven cases of SCARs were expected, based on the estimated historical incidence of allopurinol induced SCARs nationwide (0.30% per year, 95% confidence interval 0.28% to 0.31%; P=0.0026; two side one sample binomial test). CONCLUSIONS: Prospective screening of the HLA-B*58:01 allele, coupled with an alternative drug treatment for carriers, significantly decreased the incidence of allopurinol induced SCARs in Taiwanese medical centres.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmj.h4848

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 209

Metadata

Authors
Ko, T.-M., Tsai, C.-Y., Chen, S.-Y., Chen, K.-S., Yu, K.-H., Chu, C.-S., Huang, C.-M., Wang, C.-R., Weng, C.-T., Yu, C.-L., Hsieh, S.-C., Tsai, J.-C., Lai, W.-T., Tsai, W.-C., Yin, G.-D., Ou, T.-T., Cheng, K.-H., Yen, J.-H., Liou, T.-L., Lin, T.-H., Chen, D.-Y., Hsiao, P.-J., Weng, M.-Y., Chen, Y.-M., Chen, C.-H., Liu, M.-F., Yen, H.-W., Lee, J.-J., Kuo, M.-C., Wu, C.-C., Hung, S.-Y., Luo, S.-F., Yang, Y.-H., Chuang, H.-P., Chou, Y.-C., Liao, H.-T., Wang, C.-W., Huang, C.-L., Chang, C.-S., Lee, M.-T. M., Chen, P., Wong, C.-S., Chen, C.-H., Wu, J.-Y., Chen, Y.-T., & Shen, C.-Y.
Venue
BMJ
Publisher
BMJ
Published
2015-09-23
Volume
351
Pages
h4848
ISSN
1756-1833 (ISSN-L)
OpenAlex
W2262559384
Cited by
209
References
2
FWCI
15.23
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study. https://app.cochat.ai/papers/10.1136/bmj.h4848
The paper
Ko, T.-M., Tsai, C.-Y., Chen, S.-Y., Chen, K.-S., Yu, K.-H., Chu, C.-S., Huang, C.-M., Wang, C.-R., Weng, C.-T., Yu, C.-L., Hsieh, S.-C., Tsai, J.-C., Lai, W.-T., Tsai, W.-C., Yin, G.-D., Ou, T.-T., Cheng, K.-H., Yen, J.-H., Liou, T.-L., . . . Shen, C.-Y. (2015). Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study. BMJ. https://doi.org/10.1136/bmj.h4848

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.